Fondazione del Piemonte per l'Oncologia IRCCS Candiolo

Candiolo 10060

2 studies enrolling now · 2 studies all time

What they study most

Non-small Cell Lung Cancer, Recurrent or Metastatic Solid Tumors

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) — Recruiting now
• Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer — Recruiting now